Covaris Launches New truCOVER® Total RNA Kit

WOBURN, MA, UNITED STATES, February 9, 2026 /EINPresswire.com/ -- Powered by AFA‑enabled workflows that deliver ...

ABL Diagnostics and CDL Pharma secure a multi year renewal of clinical services with a long standing Pharma partner

The multi‑year renewal strengthens ABL’s integrated platform, improving revenue visibility and supporting the Group’s ...

ABL Diagnostics Strengthens Strategic Supplier Agreements to Support Accelerated Growth

The renewed and expanded agreements provide improved commercial conditions, including more competitive pricing, optimized contractual terms, and enhanced supply security. These improvements will ...

All Invest Securities Flash Update to the Equity Research Coverage of ABL Diagnostics (For Professional Investors)

Strong Buy reiterated with a €8.37 target price following the 21 January 2026 Flash; last close on 22 January 2026: ...

Transforming Genetic Testing with Flexibility and Control

GeneMetrics was established by a group of clinicians, scientists, and legal experts committed to addressing a fragmented ...
AHA/ASA Journals

HEV-Targeted Antibody-Drug Conjugate Promotes Long-Term Cardiac Allograft Acceptance

BACKGROUND: The entrance of naive T cells into lymph nodes (LNs) is a crucial step for induction of heart transplant acceptance under costimulatory blockade. Specialized blood vessels within the LN ...